- $44.11m
- $319.20m
- $212.37m
- 11
- 64
- 36
- 30
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -52.87% | ||
| Return on Equity | n/a | ||
| Operating Margin | -67.35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 181.71 | 147.68 | 231.27 | 252.4 | 212.37 | 162.87 | 176.88 | 5.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Directors
- J. Daniel Plants NEC (54)
- David Mowry CEO (58)
- Rohan Seth CFO (43)
- Sheila Hopkins DRC (65)
- Juliane Park DRC
- Janet Widmann DRC (54)
- Gregory Barrett IND (67)
- Timothy O'Shea IND (68)
- Joseph Whitters IND (63)
- Katherine Zanotti IND (66)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 10th, 1998
- Public Since
- March 31st, 2004
- No. of Employees
- 540
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 19,960,622
- Address
- 3240 Bayshore Blvd, BRISBANE, 94005-1021
- Web
- https://www.cutera.com/
- Phone
- +1 4156575500
- Contact
- Greg Barker
- Auditors
- BDO USA, LLP
Upcoming Events for CUTR
Cutera Inc Annual Shareholders Meeting
Q2 2024 Cutera Inc Earnings Release
Similar to CUTR
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Cutera share price?
As of Today at 19:06 UTC, shares in Cutera are trading at $2.21. This share price information is delayed by 15 minutes.
How has the Cutera share price performed this year?
Shares in Cutera last closed at $2.21 and the price had moved by -89.71% over the past 365 days. In terms of relative price strength the Cutera share price has underperformed the S&P500 Index by -91.69% over the past year.
What are the analyst and broker recommendations for Cutera?
The overall consensus recommendation for Cutera is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Cutera dividend yield?
Cutera does not currently pay a dividend.
Does Cutera pay a dividend?
Cutera does not currently pay a dividend.
When does Cutera next pay dividends?
Cutera does not currently pay a dividend.
How do I buy Cutera shares?
To buy shares in Cutera you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cutera?
As of the previous close price of $2.21, shares in Cutera had a market capitalisation of $44.11m.
Where are Cutera shares listed?
Here are the trading details for Cutera:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CUTR
What kind of share is Cutera?
Based on an overall assessment of its quality, value and momentum Cutera is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cutera share price forecast for 2024?
The analyst consensus target price for shares in Cutera is $6.33. That is 186.43% above the last closing price of $2.21.
Analysts covering Cutera currently have a consensus Earnings Per Share (EPS) forecast of -$3.88 for the next financial year.
What is the trend in the Cutera share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cutera. Over the past six months, its share price has underperformed the S&P500 Index by -45%.
As of the last closing price of $2.21, shares in Cutera were trading -63.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cutera PE Ratio?
The Cutera PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cutera?
Cutera's management team is headed by:
- J. Daniel Plants - NEC
- David Mowry - CEO
- Rohan Seth - CFO
- Sheila Hopkins - DRC
- Juliane Park - DRC
- Janet Widmann - DRC
- Gregory Barrett - IND
- Timothy O'Shea - IND
- Joseph Whitters - IND
- Katherine Zanotti - IND